Freakonomics, M.D. cover image

73. Who Pays for Multimillion-Dollar Miracle Cures?

Freakonomics, M.D.

00:00

Sickle Cell Disease

The CRISPR-based treatment that cured Jimmy Olaher is now up for FDA approval. If our drug financing landscape doesn't change, the cure will remain out of reach for many patients who need it. Imagine a future where organizations and governments across the globe collaborate to eradicate sickle cell disease everywhere. Like they pledged to do with polio, 33 years after an American scientist developed the first successful vaccine.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app